Serum/plasma stability evidence — ADMETatlas

Browse

Evidence·Metabolic & Proteolytic Stability

Comparable

Serum/plasma stability evidence

ATLXM0000573 · 67 minutes

Home
Evidence

ADMETatlas

peptide evidence atlas

ADMETatlas is an open, curated atlas of ADMET evidence for therapeutic peptides — spanning developability, membrane permeability and blood–brain-barrier transport, immune-recognition context, and approved-product context. Every measurement stays linked to its original source, with stable identifiers and transparent curation, so results can be traced, cited, and reproduced.

Browse

Peptides Products Evidence Context signals Descriptors

Resource

Developability Comparator

Peptides

Developability

Profile Comparator

Resources

Manual Explanations Statistics Download License About

Serum/plasma stability

Measurement

ATLXM0000573

Peptide: ATLPC0025294
Measured material: Specific molecular form
Endpoint: Serum/plasma stability
ADMET domain: Metabolic & Proteolytic Stability
Value: 67 minutes
Normalized value: 4,020 seconds
Evidence role: Comparable: structured measurement intended for within-endpoint comparison when assay context matches
Assay / model: RP-HPLC · mouse · Mouse serum
Condition: Dose/window: 100 μg/mL · Mouse serum proteases · in vitro
Scientific source: DOI: 10.1034/j.1399-3011.1999.00094.x
Source: PEPlife2
Open DOI

Stack